And how will both fare against other treatments, such as Visudyne, the gold standard from QLT Therapeutics (nasdaq: QLTI - news - people ) and Novartis (nyse: NVS - news - people ) and Alcon 's (nyse: ALC - news - people ) experimental Retaane.

FORBES: Pfizer Vs. Genentech